Fundraising FoxNemaMetrix
Eugene, US · Founded 2011 · Oregon corporation · 2 known investors
Find your way into NemaMetrix
Sign up to see every warm intro you have to NemaMetrix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NemaMetrix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
NemaMetrix was founded in 2011 by Janis Weeks and Shawn Lockery.
JW
Janis WeeksCo-founderWeeks is an academic neuroscientist and co-founder of InVivo Biosystems, a University of Oregon spin-off company, with expertise in neurophysiology and neural circuit research. She has spent over three decades in neuroscience education and research, with work spanning drug development, disease modeling, and technology development.
MB
Matt BeaudetNamed on SEC filing
Investors · 2
Oregon Venture FundreportedPortland · $500K – $5M
How we know: funding news · Not right? Tell us
Rogue Venture PartnersreportedSan Antonio
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$9.4M disclosed across 5 of 6 rounds · 2015–2019
▶$5.2MraisedFeb 2019 · 8 investors · BiotechnologyRule 506(b)
▶$5.2MraisedFeb 2019 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- EVANGELINE GONZALEZDirector
- SHAWN LOCKERYExecutive Officer, Director
- MATT BEAUDETExecutive Officer, Director
- RICK MILLERDirector
- ANN BUNNENBERGDirector
- CHRIS CARLSONDirector
- KEVIN PADRICKDirector
- Offering amount
- $6.5M
- Amount sold
- $5.2M
- First sale
- Feb 2019
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 06b
▶$1.6MraisedApr 2018 · 2 investors · BiotechnologyRule 506(b)
▶$1.6MraisedApr 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Trisha BrockDirector
- Matt BeaudetExecutive Officer, Director
- Janis WeeksExecutive Officer, Director
- Amy TykesonDirector
- Chris CarlsonDirector
- Chris HopkinsDirector
- Shawn LockeryExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Apr 2018
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 04, 06b, 4a5
▶$2.5MraisedMar 2017 · 23 investors · BiotechnologyRule 506(b)
▶$2.5MraisedMar 2017 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matt BeaudetExecutive Officer, Director
- Amy TykesonDirector
- Shawn LockeryExecutive Officer, Director
- Janis WeeksExecutive Officer, Director
- Chris CarlsonDirector
- Offering amount
- $3M
- Amount sold
- $2.5M
- First sale
- Feb 2017
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 06b, 4a5
▶$249.6KofferedApr 2016 · BiotechnologyRule 506(b)
▶$249.6KofferedApr 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn LockeryExecutive Officer, Director
- Amy TykesonDirector
- Chris CarlsonDirector
- Janis WeeksExecutive Officer, Director
- Matt BeaudetExecutive Officer, Director
- Offering amount
- $249.6K
- Incorporated
- Corporation, Oregon, 2011
- Federal exemptions
- 06b
▶$150KraisedSep 2015 · 1 investors · BiotechnologyRule 506(b)
▶$150KraisedSep 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Janis WeeksExecutive Officer, Director
- Matt BeaudetExecutive Officer, Director
- Shawn LockeryExecutive Officer, Director
- Offering amount
- $825K
- Amount sold
- $150K
- First sale
- Sep 2015
- Incorporated
- Corporation, Oregon, 2011
- Federal exemptions
- 06b
▶$20.6KraisedSep 2015 · 1 investors · BiotechnologyRule 506(b)
▶$20.6KraisedSep 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Janis WeeksExecutive Officer, Director
- Matt BeaudetExecutive Officer, Director
- Shawn LockeryExecutive Officer, Director
- Offering amount
- $20.6K
- Amount sold
- $20.6K
- Minimum investment
- $20.6K
- First sale
- Aug 2015
- Incorporated
- Corporation, Oregon, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 10 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $388.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $464.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $474.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $664.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $986.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $350K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $149.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $158.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded NemaMetrix?
- NemaMetrix was founded by Janis Weeks, Shawn Lockery in 2011.
- Who are NemaMetrix's investors?
- NemaMetrix's investors include Oregon Venture Fund, Rogue Venture Partners.
- How much funding has NemaMetrix raised?
- NemaMetrix has disclosed $9.4M raised across 5 of its 6 known rounds.
- Where is NemaMetrix headquartered?
- NemaMetrix is headquartered in Eugene, US.